September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the treatment of acute coronary syndromes (ACS), specifically in patients with unstable angina or non-segment elevation myocardial infarction (NSTEMI), which could replace heparin in patients undergoing angioplasty.

September 25, 2007 - The Sorin Group, a European cardiovascular company, announced today that it has received FDA clearance for marketing its MEMO 3D Semirigid Annuloplasty Ring in the U.S., targeting patients receiving mitral valve repair as therapy for mitral valve disease.

Annuloplasty rings are indicated for repair of the mitral valve and are designed to remodel the anatomical shape of the mitral annulus, preventing further dilatation and minimizing the risk of late repair failures.

The FIRE STAR Rx PTCA Dilatation Catheter and the DURA STAR Rx PTCA Dilatation Catheter are indicated for expansion in the narrowed area of a coronary artery or bypass graft. The FIRE STAR Balloon features the lowest pre-dilatation profile in the market.

September 24, 2007 - Stentys announced that its drug-eluting bifurcated stent for treatment of blocked coronary artery bifurcations was implanted in a patient, marking the first human implantation of the stent.

The implant was completed in reportedly routine interventional time, and the patient was released from the ICU within hours of the implantation of the Stentys bifurcated stent and was discharged from the hospital shortly after the procedure.

September 21, 2007 - Catheter angiography may be unnecessary in cases where the CT angiogram (CTA) is indeterminate for aortic injury, according to a study conducted by radiologists at the University of Washington and the Harborview Injury Prevention and Research Center in Seattle, WA.

September 21, 2007-The CYPHER Sirolimus-eluting Coronary Stent reduced by more than half the rate of major adverse cardiac events (MACE) compared to the Taxus Stent in small coronary vessels, according to data appearing this week in the Journal of the American College of Cardiology.

September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.

September 20, 2007 - Cook Medical and Cardica Inc. announced that they have expanded their original agreement regarding the development of vascular closure devices, in which Cook Medical will pay Cardica up to $750,000 for the development of an additional product for the closure device product line.

September 19, 2007 - Biotronik announced that it has been awarded a full-service cardiac rhythm management (CRM) contract with Premier Purchasing Partners L.P., a healthcare purchasing alliance, which will allow Premier members to purchase Biotronik pacemakers, implantable defibrillators and cardiac resynchronization devices at exceptional savings.

The new agreement marks the first time that Biotronik has offered its full product portfolio to the Premier alliance on contract.

September 19, 2007 - MedicalCV Inc. announced that the first closed-chest, beating heart cardiac ablation using the SOLAR Surgical Ablation System was performed, marking a growing trend in minimally invasive surgical ablation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now